Inovent Granted Extension to Complete Qualifying Transaction

inoVent

NEWS RELEASE

Inovent Granted Extension to Complete Qualifying Transaction

Vancouver, British Columbia, September 19, 2016 – Inovent Capital Inc. (TSX Venture - IVQ.P, "Inovent” or the “Company") is pleased to report that the TSX Venture Exchange (the “Exchange”) has accepted the Company’s application for an extension to December 20, 2016 to complete its Qualifying Transaction (“QT”), consisting of the acquisition of the King’s Point gold-copper-zinc property (“King’s Point”). The previous deadline had been September 21, 2016.

Prior to December 20, 2016, the Company is required to complete the acquisition of King’s Point, with this requirement being satisfied by the Exchange issuing a Final Exchange Bulletin that evidences final Exchange Acceptance and the closing of the QT. If this requirement is not met, then the Company’s shares will be transferred to the NEX board of the Exchange.

Regarding the Company’s trading status, reinstatement to trading can occur either when the Company completes its QT in accordance with Exchange Policy 2.4 or upon application for reinstatement, satisfactory to the Exchange, at the time of its transfer to NEX.

On behalf of the board of Inovent:

INOVENT CAPITAL INC.

Per: “David Brett”

David H. Brett, MBA Chief Executive Officer & Director

For more information please contact:

John Gomez, Director Tel. 604-484-7118 [email protected]

David Brett Tel. 604-682-2421 [email protected] www.inoventcapital.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Inovent Capital Inc. Suite 1130 – 400 Burrard Street, Vancouver, BC Canada V6C 3A6 www.inoventcapital.com